Comprehensive biomarker profiling in patients with obstructive sleep apnea

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 340-346

  Maeder, Micha T ^a,b   Strobel, Werner ^a   Christ, Michael ^a,c   Todd, John ^d   Estis, Joel ^d   Wildi, Karin ^a   Thalmann, Gregor ^a   Hilti, Jonas ^a   Brutsche, Martin ^a,b   Twerenbold, Raphael ^a   Rickli, Hans ^b   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c Department of Emergency and Critical Care Medicine   (Germany)

^d SINGULEX INC   (United States)

Author keywords

Biomarkers; Diurnal changes; Multimarker; Obstructive sleep apnea syndrome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; GELATINASE B; INSULIN; INTERLEUKIN 6; TROPONIN I; VASCULOTROPIN; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HEART STRESS; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXYGEN SATURATION; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SLEEP; SLEEP DISORDERED BREATHING; STRUCTURED INTERVIEW; TURNOVER TIME; AGED; BLOOD; PROCEDURES; SLEEP APNEA, OBSTRUCTIVE;

ADULT; AGED; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84924588719     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.09.005     Document Type: Article

References (22)

1. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
2. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
3. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. Third universal definition of myocardial infarction. Eur Heart J 2012, 33:2551-2567.
4. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
5. Montesi S.B., Bajwa E.K., Malhotra A. Biomarkers of sleep apnea. Chest 2012, 142:239-245.
6. Ljunggren M., Lindahl B., Theorell-Haglow J., Lindberg E. Association between obstructive sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women. Sleep 2012, 35:1521-1527.
7. Tasci S., Manka R., Scholtyssek S., Lentini S, Troatz C, Stoffel-Wagner B, et al. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol 2006, 95:23-30.
8. Hoekema A., Voors A.A., Wijkstra P.J., Stegenga B, van der Hoeven JH, Tol CG, et al. Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides. Int J Cardiol 2008, 128:232-239.
9. Maeder M.T., Ammann P., Rickli H., Schoch OD, Korte W, Hurny C, et al. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath 2008, 12:7-16.
10. Hubner R.H., El Mokhtari N.E., Freitag S., Rausche T, Goder R, Tiroke A, et al. NT-proBNP is not elevated in patients with obstructive sleep apnoea. Respir Med 2008, 102:134-142.
11. Vartany E., Imevbore M., O'Malley M., Manfredi C, Pasquarella C, Scinto L, et al. N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome. J Sleep Res 2006, 15:424-429.
12. Patwardhan A.A., Larson M.G., Levy D., Benjamin EJ, Leip EP, Keyes MJ, et al. Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep 2006, 29:1301-1306.
13. von Kanel R., Natarajan L., Ancoli-Israel S., Mills P.J., Loredo J.S., Dimsdale J.E. Day/night rhythm of hemostatic factors in obstructive sleep apnea. Sleep 2010, 33:371-377.
14. Barcelo A., Pierola J., de la Pena M., Esquinas C, Sanchez-de la Torre M, Ayllon O Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J 2012, 39:913-918.
15. Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 2004, 50:1104-1106.
16. Sokoll L.J., Baum H., Collinson P.O., Gurr E, Haass M, Luthe H, et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 2004, 42:965-972.
17. Todd J., Freese B., Lu A., Held D, Morey J, Livingston R, et al. Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem 2007, 53:1990-1995.
18. Arnardottir E.S., Maislin G., Schwab R.J., Staley B, Benediktsdottir B, Olafsson I, et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012, 35:921-932.
19. Drager L.F., Togeiro S.M., Polotsky V.Y., Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and metabolic syndrome. J Am Coll Cardiol 2013, 62:569-576.
20. Maeder M.T., Ammann P., Munzer T., Schoch OD, Korte W, Hurny C, et al. Continuous positive airway pressure improves exercise capacity and heart rate recovery in obstructive sleep apnea. Int J Cardiol 2008, 132:75-83.
21. Wu A.H., Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. Eur J Heart Fail 2004, 6:355-358.
22. Randby A., Namtvedt S.K., Einvik G., Hrubos-Strom H, Hagve TA, Somers VK, et al. Obstructive sleep apnea is associated with increased high-sensitivity cardiac troponin T levels. Chest 2012, 142:639-646.